Two prostate cancer mutations reveal opposite responses to ferroptosis therapy

MedicalXpress | июл 02, 2026

A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine whether prostate cancers are susceptible to a type of cell death known as ferroptosis. These findings, published in Nature Communications, could help guide treatment strategies for patients whose tumors do not respond to current treatment options.